Bio-Rad Laboratories, Inc. (BIO-B) is expected to report earnings on Thursday, October 22, 2026, after the close. Estimated release time 16:17 ET. Consensus EPS estimate is $2.23.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-30 | Mar 2026 qtr | $2.01 | $1.89 | -6.0% | $592.10M |
| 2025-10-29 | Sep 2025 qtr | $1.89 | $2.26 | — | $653.00M |
| 2025-05-01 | Mar 2025 qtr | $1.82 | $2.29 | — | $585.40M |
| 2025-02-14 | Dec 2024 qtr | $2.86 | $2.90 | +1.4% | $667.48M |
| 2024-08-02 | Jun 2024 qtr | $2.05 | $3.11 | — | $638.48M |
| 2023-10-27 | Sep 2023 qtr | $2.76 | $3.65 | — | $632.12M |
| 2023-08-04 | Jun 2023 qtr | $2.64 | $3.00 | +13.6% | $681.11M |
| 2023-05-05 | Mar 2023 qtr | $3.63 | $2.33 | — | $676.84M |
BIO-B has beaten consensus EPS in 2 of its last 3 scored quarters.
See BIO-B on the live calendar →